A new analysis has found that many women with breast cancer lack knowledge about their illness, with minority patients less likely than white patients to know and report accurate information about their tumors’ characteristics.
Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings highlight the need to educate patients about their…Continue
Added by Peter Hofland, PhD on January 29, 2015 at 9:30am — No Comments
Findings of a study published in in BJU International suggest that among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer. The authors of the study found that smoking may negatively affect the health outcomes of patients with prostate cancer and may contribute to complications related to their care.…
Added by Editorial Team on January 27, 2015 at 5:30pm — No Comments
Borderline ovarian tumors (BOTs) were first described by Taylor in 1929 and have been a challenge for both pathologists and oncologists. For the group of patients with advanced stage disease, particularly those with invasive implants, there is no consensus regarding standard therapy.
Some oncologists would agree that adjuvant treatment is warranted for these patients, based on their worse prognosis and the tendency of these tumors to recur, not only as BOT but also as a low-grad…Continue
Added by Ines Isabel Monteiro Vasconcelos on January 23, 2015 at 6:30am — No Comments
A study published in Clinical Cancer Research, a journal of the American Association for Cancer Research shows that among patients who had an unidentifiable lung nodule detected by a chest CT scan, testing sputum for a panel of three microRNA (miRNA) biomarkers successfully distinguished early-stage lung cancers from nonmalignant nodules most of the time.
“We are facing a tremendous rise in the number of lung nodules identified because of the increasing implementation of the…Continue
Added by Editorial Team on January 15, 2015 at 5:30pm — No Comments
A study published in Cancer Research, a journal of the American Association for Cancer Research suggests that postmenopausal women who were metabolically unhealthy, as assessed by insulin abnormalities, were at increased risk for breast cancer compared with their metabolically healthy counterparts. This was the case for both overweight and normal-weight individuals.
The study was a collaborative project between the lead author, Marc J. Gunter, PhD, associate…Continue
Added by Editorial Team on January 15, 2015 at 5:17pm — No Comments
Bristol-Myers Squibb Company and Eli Lilly and Company have agreed to collaborate on the evaluation of the safety, tolerability and preliminary efficacy of the immunotherapy nivolumab (Opdivo®; Bristol-Myers Squibb) in combination with galunisertib (LY2157299; Lilly and Company).
The Phase I/II trial will evaluate the investigational combination of nivolumab and galunisertib as a potential treatment option for patients with advanced (metastatic and/or unresectable) glioblastoma,…Continue
Added by Editorial Team on January 13, 2015 at 4:30pm — No Comments
Seattle Genetics, Inc. and Bristol-Myers Squibb Company have entered into a clinical trial collaboration to evaluate the investigational combination of the antibody-drug conjugate or ADC brentuximab vedotin (Adcetris®; Seattle Genetics) and the immunotherapy nivolumab (Opdivo®; Bristol-Myers Squibb) in two planned Phase I/II clinical trials. The first trial will evaluate the combination of brentuximab vedotin and nivolumab as a potential treatment option for patients with relapsed or…Continue
Added by Editorial Team on January 13, 2015 at 2:18pm — No Comments